人源性抗bFGF单链抗体表达载体的构建与酵母表达

中国生物工程杂志

2012, Vol. 32

Issue (05): 31-35

研究报告

人源性抗bFGF单链抗体表达载体的构建与酵母表达

吕卫东¹, 杜超超¹, 王宏¹, 姜浩武¹, 劳学军², 宋其芳¹, 邓宁¹

1. 广东省分子免疫与抗体工程重点实验室暨南大学抗体工程研究中心广州 510633;
2. 暨南大学第一临床学院广州 510632

High Level Expression of Human ScFv against bFGF in Pichia pastoris

LV Wei-dong¹, DU Chao-chao¹, WANG Hong¹, JIANG Hao-wu¹, LAO Xue-jun², SONG Qi-fang¹, DENG Ning¹

1. Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou 510632, China;
2. Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China

全文: PDF(508 KB) HTML

摘要：

为了提高人源性抗bFGF抗体的表达量,从噬菌体抗体库筛选出的人源性抗bFGF抗体基因中亚克隆单链抗体(single chain fragment variable,ScFv)基因,并将其构建到酵母表达载体pPICZαA中。表达载体质粒经线性化后,电转化法转化至毕赤酵母GS115中,甲醇诱导表达。表达产物经镍离子亲和层析和阴离子交换层析纯化,并检测其生物学活性。酶切鉴定结果显示人源性的酵母表达载体构建成功。SDS-PAGE和Western blot结果显示,抗bFGF单链抗体获得了高效表达,表达量可达124mg/L,目的蛋白大小为36 kDa左右。通过两步纯化方案,目的蛋白的纯度可达95%以上。ELISA结果显示纯化的目的蛋白可与bFGF特异性结合。CCK8检测结果显示,纯化的抗bFGF单链抗体可剂量依赖性地抑制人肺腺癌细胞株A549的增殖。研究结果表明在毕赤酵母中可获得人源性抗bFGF单链抗体高效表达,表达产物具有很好的生物学活性。

关键词： bFGF; 单链抗体; 毕赤酵母; 肺癌

Abstract:

In order to high level express anti-bFGF ScFv antibody in Pichia pastoris, the gene of human anti-bFGF ScFv was subcloned, and constructed into expression vector pPICZαA. The constructed expression vector pPICZαA-ScFv was linearised and transformed to Pichia pastoris by electroporation. The transformants were induced by methanol, and the anti-bFGF ScFv was expressed. The expression products were purified by affinity chromatography of Ni-Seproase 6 FF and ion exchange chromatography of DEAE Sepharose FF. The results of SDS-PAGE and Western blotting showed that anti-bFGF ScFv was high level expressed successfully and the expression quantity was about 124mg/L. The target protein was purified from the expression products and the purity was more than 95 %. The results of ELISA showed that the purified recombinant ScFv could combine with bFGF specifically. The results of CCK8 showed that the purified recombinant ScFv could inhibit the proliferation of A549 cells in a dose-dependent manner in vitro. The results demonstrated that the anti-bFGF ScFv can be high level expressed in Pichia pastoris with good biological activity.

Key words: bFGF ScFv Pichia pastoris Lung cancer

收稿日期: 2012-01-05 出版日期: 2012-05-25

ZTFLH:

Q789

基金资助:

国家"863"计划资助项目(2009AA02Z112)

通讯作者: 邓宁 E-mail: tdengn@jnu.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

吕卫东, 杜超超, 王宏, 姜浩武, 劳学军, 宋其芳, 邓宁. 人源性抗bFGF单链抗体表达载体的构建与酵母表达[J]. 中国生物工程杂志, 2012, 32(05): 31-35.

LV Wei-dong, DU Chao-chao, WANG Hong, JIANG Hao-wu, LAO Xue-jun, SONG Qi-fang, DENG Ning. High Level Expression of Human ScFv against bFGF in Pichia pastoris. China Biotechnology, 2012, 32(05): 31-35.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I05/31

[1] Hicklin D J, Ellis L M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Clin Oncol, 2005, 23(5): 1011-1027.

[2] Mason J C, Lidington E A, Ahmad S R, et al. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physio, 2002, 282(3): 578-587.

[3] Nissen L J, Cao R H, Hedlund E M, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest, 2007, 117(10): 2766-2777.

[4] Sun X T, Ding Y T, Yan X G, et al.Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system. World J Gastroenterol, 2004, 10(17): 2524-2528.

[5] Horstmann M, Merseburger A S, Heyde E V, et al. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels. J Cancer Res Clin Oncol, 2005, 131 (11): 715-722.

[6] 李艳, 王新允, 刘婷, 等. 组织芯片技术研究肺癌及癌前病变bFGF的表达及意义. 中华肿瘤防治杂志, 2005, 12(9): 668-671. Li Y, Wang X Y, Liu T, et al. Expression and significance of bFGF in lung cancer detected by tissue microarray technology.Chinese Journal of Cancer Prevention and Treatment, 2005, 12(9): 668-671.

[7] 龚义平, 陶俊, 王宏, 等. 嵌合内含子对抗bFGF抗体基因在293T细胞中表达的影响. 中国生物工程杂志, 2010, 30(3): 9-14. Gong Y P, Tao J, Wang H, et al. Effect of Chimeric Intron on the Expression of Anti-bFGF Antibody Genes in 293T Cells.China Biotechnology, 2010, 30(3): 9-14.

[8] Tao J, Xiang J J, Li D, et al. Selection and characterization of a fully human neutralizing antibody to human fibroblast growth factor-2. Biochem Biophys Res Commun, 2010, 394(3): 767-773.

[9] Wayne A S, Kreitman R J, Findley H W, et al. Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res, 2010, 16(6): 1894-1903.

[10] 陈耀祖, 张娟, 王旻. 用于抗体/抗体片段表达的系统及其高表达策略. 中国生物工程杂志, 2011, 31(9): 76-81. Chen Y Z, Zhang J, Wang M. The Expression System of Antibody and Antibody Fragment and Strategy of High-level Production. China Biotechnology, 2011, 31(9): 76-81.

[11] Damasceno L M, Pla I, Chang H J, et al. An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Protein Expr Purif, 2004, 37(1): 18-26.

[12] 夏钰弘, 杨国仪, 洪建刚, 等. IGFBP-3、bFGF、Ki-67蛋白在非小细胞肺癌组织中的表达及意义. 江苏医药, 2009, 35(1): 41-43. Xia Y H, Yang G Y, Hong J G, et al. Preclinical progress in targeted therapies for non-small cell lung cancer.Jiangsu Medical Journal, 2009, 35(1): 41-43.

[13] 谭晓红, 杨晓. 非小细胞肺癌靶向治疗的临床前研究进展. 生命科学, 2011, 23(4): 353-358. Tan X H, Yang X. Expression and significance of IGFBP-3,bFGF and Ki-67 in non-small cell lung cancer. Chinese Bulletin of Life Science, 2011, 23(4): 353-358.

[14] Li D, Wang H, Xiang J J, et al. Monoclonal antibodies targeting basic fibroblast growth factor inhibit the growth of B16 melanoma in vivo and in vitro. Oncol Rep, 2010, 24 (2): 457-463.

[1]	陈中伟,郑璞,陈鹏程,吴丹. 耐热植酸酶突变体的筛选及性质研究 ^*[J]. 中国生物工程杂志, 2021, 41(2/3): 30-37.
[2]	陈鑫洁,钱芷兰,刘启,赵清,张元兴,蔡孟浩. 毕赤酵母底盘芳香族氨基酸合成途径改造生产肉桂酸及对香豆酸^*[J]. 中国生物工程杂志, 2021, 41(10): 52-61.
[3]	石鹏程, 纪晓俊. 酵母系统表达人表皮生长因子研究进展 ^*[J]. 中国生物工程杂志, 2021, 41(1): 72-79.
[4]	李彤彤,宋彩玲,杨凯越,王文静,陈慧宇,刘明. 抗犬细小病毒VP2蛋白单链抗体的制备与中和活性研究 ^*[J]. 中国生物工程杂志, 2020, 40(4): 10-16.
[5]	张潘红,李莲莲,张秀美,崔家骏,姜银杰. microRNA对肺癌化疗耐药性影响的研究进展 ^*[J]. 中国生物工程杂志, 2019, 39(7): 79-84.
[6]	田园,李艳玲. 基于重组毕赤酵母的fusaruside生物合成 ^*[J]. 中国生物工程杂志, 2019, 39(7): 8-14.
[7]	彭强强,刘启,徐名强,张元兴,蔡孟浩. 新型重组毕赤酵母产人胰岛素前体的表达工艺研究 ^*[J]. 中国生物工程杂志, 2019, 39(7): 48-55.
[8]	严建,贾禄强,丁健,史仲平. 甲醇周期诱导控制强化毕赤酵母生产猪α干扰素 ^*[J]. 中国生物工程杂志, 2019, 39(6): 32-40.
[9]	姚银,闵琪,熊海容,张莉. 木聚糖酶和甘露聚糖酶在毕赤酵母中的共表达及产酶分析 ^*[J]. 中国生物工程杂志, 2019, 39(3): 37-45.
[10]	安明晖,田文,韩晓旭,尚红. 表达HIV单链抗体的重组乳酸杆菌的构建及表型分析 ^*[J]. 中国生物工程杂志, 2019, 39(10): 1-8.
[11]	张文玉,魏东升,钱江潮. 共表达PDI1、MDH1和HAC1基因对重组毕赤酵母分泌表达葡糖氧化酶的影响 ^*[J]. 中国生物工程杂志, 2019, 39(10): 24-33.
[12]	王彤,徐岩,喻晓蔚. 毕赤酵母Kex2蛋白酶的同源表达及酶学性质 ^*[J]. 中国生物工程杂志, 2019, 39(1): 38-45.
[13]	程功,焦思明,任立世,冯翠,杜昱光. 枯草芽孢杆菌壳聚糖酶水解制备低脱乙酰度壳寡糖及其组分分析 ^*[J]. 中国生物工程杂志, 2018, 38(9): 19-26.
[14]	唐健雪,肖永乐,彭俊杰,赵世纪,万小平,高荣. 融合抗菌肽基因在重组毕赤酵母的表达及体外活性研究 ^*[J]. 中国生物工程杂志, 2018, 38(6): 9-16.
[15]	张潘潘,许延吉,王之可,刘晓,李素霞. 重组猪胰蛋白酶及其R122位点突变体在毕赤酵母中的高效表达及其性质研究[J]. 中国生物工程杂志, 2018, 38(5): 56-65.

Viewed

Full text

Abstract

Cited

Shared

Discussed